Literature DB >> 8137316

Phenotypic and genotypic events in gastric carcinogenesis.

P Correa1, Y H Shiao.   

Abstract

Two main histological variants of gastric carcinoma have been identified: intestinal and diffuse types. The former is preceded by a sequential chain of events characterized as chronic gastritis, atrophy, intestinal metaplasia, dysplasia, intramucosal carcinoma, and invasive neoplasia. The second type (diffuse) lacks well-recognized precursor changes. Genotypic events in the gastric precancerous process are described, but a clear model of their sequence and relevance is lacking. Cadherins may play a role in determining which type of carcinoma develops. Translocated promoter region-MET rearrangements have been identified since early stages of the process. p53 alterations are reported beginning with the dysplasia stage utilizing immunohistochemical techniques. Single-strand conformation polymorphism and sequencing analysis show alterations in early stages, especially G:C to A:T transitions.

Entities:  

Mesh:

Year:  1994        PMID: 8137316

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  70 in total

1.  Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions.

Authors:  M Rugge; M Cassaro; G Pennelli; V M Russo; F Di Mario; F Farinati
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

2.  Expression of 1A6 gene and its correlation with intestinal gastric carcinoma.

Authors:  Yi-Qiang Liu; Hong Zhao; Tao Ning; Yang Ke; Ji-You Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 3.  Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability.

Authors:  Leon P Bignold
Journal:  Int J Exp Pathol       Date:  2005-04       Impact factor: 1.925

4.  Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions.

Authors:  Hong-Jun Li; Er-Hu Fang; Jian-Qun Wang; Li-Duan Zheng; Qiang-Song Tong
Journal:  Curr Med Sci       Date:  2020-03-13

5.  Telomere length is correlated with mitochondrial DNA copy number in intestinal, but not diffuse, gastric cancer.

Authors:  Soo-Jung Jung; Ji-Hyoung Cho; Won-Jin Park; Yu-Ran Heo; Jae-Ho Lee
Journal:  Oncol Lett       Date:  2017-05-17       Impact factor: 2.967

6.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.

Authors:  Jae-Hyuk Lee; Susan C Abraham; Hyun-Soo Kim; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 7.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

8.  Poorly differentiated adenocarcinoma with signet-ring cell carcinoma in a hyperplastic polyp of the stomach: report of a case.

Authors:  Hiroshi Hirano; Toshimi Yoshida; Hitoshi Yoshimura; Masato Fukuoka; Eriko Ohkubo; Shiro Tachibana; Hiroshi Saito; Keiji Nakasho; Takashi Nishigami
Journal:  Surg Today       Date:  2007-09-26       Impact factor: 2.549

9.  A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression.

Authors:  Hyoungseok Ju; Byungho Lim; Minjin Kim; Yong Sung Kim; Woo Ho Kim; Chunhwa Ihm; Seung-Moo Noh; Dong Soo Han; Hang-Jong Yu; Bo Youl Choi; Changwon Kang
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

10.  Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma.

Authors:  Lin Wang; Xiao-Ying Zhang; Ling Xu; Wen-Jun Liu; Juan Zhang; Jian-Ping Zhang
Journal:  Oncol Lett       Date:  2011-04-14       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.